$PASG
Passage BIO, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Philadelphia, PA
PASG chart
What traders are saying about $PASG
Latest postsPassage BIO, Inc. news
- Passage Bio, Inc. Estimates – NASDAQ:PASG
TradingView ·
- Passage Bio (PASG) Stock Forecast and Price Target 2026
MarketBeat ·
- Investigations launched into merger fairness fo...
Pluang ·
- PASG Q2 2026 Earnings: Narrower-Than-Expected Loss Offers Only a Modest Offset as Shares Slip - Return On Equity
https://www.dars.gov.et/ ·
- Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE
StreetInsider ·
- PASG Stock Alert: Halper Sadeh LLC is Investigating Whether Passage Bio, Inc. is Obtaining a Fair Price for its Shareholders
Business Wire ·
- Passage Bio amends merger terms: what it means for Passage Bio stock
AD HOC NEWS ·
- Law firm investigates fairness of mergers for U...
Pluang ·
- $HAREHOLDER ALERT: IS IT A FAIR DEAL FOR YOU? The M&A Class Action Firm Is Investigating the Merger — UTZ, SAFT, PASG and FNWD
Carroll County Mirror-Democrat ·
- Remix to go public in reverse merger with once high-flying Passage Bio
biopharmadive.com ·
- SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today
stocktwits.com ·
- PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff?
stocktwits.com ·
Passage BIO, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$45.5M | -$64.8M | -$102.1M | -$136.1M |
| Diluted EPS | $-14.35 | $-21.04 | $-1.86 | $-2.50 |
| Total assets (year end) | $62.3M | $102.4M | $150.5M | $243.5M |
| Cash and equivalents (year end) | $46.3M | $37.6M | $21.7M | $34.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Passage BIO, Inc.
- Ticker
- PASG (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Philadelphia, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1787297
Frequently asked questions
What exchange is Passage BIO, Inc. listed on?
Passage BIO, Inc. trades on the Nasdaq under the ticker symbol PASG.
What industry is Passage BIO, Inc. in?
Passage BIO, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Passage BIO, Inc. headquartered?
Passage BIO, Inc.'s business address on file with the SEC is in Philadelphia, PA.
When does Passage BIO, Inc.'s fiscal year end?
Passage BIO, Inc.'s fiscal year ends on December 31.